Esperion Therapeutics
ESPR
#6169
Rank
S$1.14 B
Marketcap
S$4.83
Share price
-1.58%
Change (1 day)
3.77%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.47 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are S$0.47 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$0.46 B71.95%
2023-12-31S$0.27 B-18.23%
2022-12-31S$0.33 B-35.57%
2021-12-31S$0.51 B10.39%
2020-12-31S$0.46 B61.65%
2019-12-31S$0.28 B47.53%
2018-12-31S$0.19 B-47.26%
2017-12-31S$0.37 B4.71%
2016-12-31S$0.35 B-15.12%
2015-12-31S$0.41 B120.84%
2014-12-31S$0.18 B90.85%
2013-12-31S$99.19 M1009.29%
2012-12-31S$8.94 M216.78%
2011-12-31S$2.82 M
2002-12-31S$89.19 M-38.49%
2001-12-31S$0.14 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$1.54 B 227.03%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$9.86 B 1,991.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$270.49 B 57,240.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$52.05 B 10,934.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$1.12 B 138.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.26 B-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA